High Tower Advisors, LLC Charles River Laboratories International, Inc. Transaction History
High Tower Advisors, LLC
- $84.5 Billion
- Q3 2025
A detailed history of High Tower Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 4,003 shares of CRL stock, worth $684,032. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,003
Previous 4,674
14.36%
Holding current value
$684,032
Previous $709,000
11.71%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding CRL
# of Institutions
639Shares Held
53.3MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$993 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$869 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$644 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$372 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$318 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.69B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...